HOME >> MEDICINE >> NEWS
FDA approves new indication for Topamax as initial monotherapy for adults and children with epilepsy

TITUSVILLE, NJ, June 30, 2005 -- The U.S. Food and Drug Administration (FDA) yesterday approved a new use for TOPAMAX (topiramate) Tablets and TOPAMAX (topiramate capsules) Sprinkle Capsules as initial monotherapy in patients 10 years of age and older with partial-onset or primary generalized tonic-clonic seizures.

Effectiveness was demonstrated in a controlled trial in patients with epilepsy who had no more than two seizures in the three months prior to enrollment. Safety and effectiveness in patients who were converted to monotherapy from a previous regimen of other anticonvulsant drugs have not been established in controlled trials.

"Anti-epilepsy medications, or neuromodulators, are selected based on seizure type; however, the specific seizure type may not always be obvious at the time of diagnosis," said Tracy Glauser, M.D., director of the Comprehensive Epilepsy Center at the Cincinnati Childrens Hospital. "A treatment like TOPAMAX, which provides coverage for both partial-onset and primarily generalized tonic-clonic seizures, offers doctors an option in situations where differentiating between these seizure types is difficult."

Epilepsy is characterized by seizures, which are abnormal electrical discharges in the brain that temporarily disrupt normal brain function. Seizures are classified as "generalized," originating in both sides of the brain simultaneously, or "partial-onset," starting in one area of the brain.

In a double-blind clinical trial, 470 patients with partial-onset or primary generalized tonic-clonic seizures were randomized to treatment with 50 mg or 400 mg/day of TOPAMAX. The primary efficacy assessment was a group comparison of time to first seizure during the double-blind phase of the study. Comparison of the Kaplan-Meier survival curves of time to first seizure favored the 400 mg/day group over the 50mg/day group. The recommended dose for monotherapy in patients 10 years of age and older is 400 mg/da
'"/>

Contact: Debbie Harvey
dharvey@golinharris.com
312-729-4374
Golin/Harris International
30-Jun-2005


Page: 1 2 3

Related medicine news :

1. DFG approves 11 new Collaborative Research Centers
2. FDA approves ZYFLO CR extended-release tablets for chronic treatment of asthma
3. FDA approves Dey, L.P.s Perforomist inhalation solution for maintenance treatment of COPD
4. VCR -- FDA approves home discharge for US patients
5. FDA approves prescription Zaditor for over-the-counter relief from itchy eyes
6. FDA approves Vectibix to treat patients with metastatic colorectal cancer
7. 5,000 rare diseases need drugs, but Europe only approves a handful each year
8. FDA approves room temperature storage of ZLB Behrings Helixate FS
9. FDA approves first blood test to predict risk for stroke
10. FDA approves Boostrix a new US vaccine for adolescents against pertussis
11. Majority of herb users dont follow evidence-based indications, researchers find

Post Your Comments:
(Date:3/30/2015)... 2015 The partners of Urgent Care ... opening of the Bella Diosa Laser Med Spa, offering ... in laser med spa treatments. , February marked the ... the partnership bridges the medical services provided by Urgent ... by Bella Diosa for both women and men. , ...
(Date:3/30/2015)... A new Zofran lawsuit ( http://www.zofranlawsuit2015.com/ ... on behalf of a child who was allegedly born ... was prescribed the anti-nausea medication during the first trimester ... Alameda Superior Court, the baby’s mother was prescribed Zofran ... in the early months of her pregnancy. The little ...
(Date:3/30/2015)... The fertility team at Ada ... asked questions to give intended parents across the globe ... , After unveiling the most affordable, non-sharing ... IVF clinic has witnessed an increase in fertility patients. ... provides attentive reproductive care — with all-inclusive IVF treatment ...
(Date:3/30/2015)... 2015 “ iCareTech ” was featured on ... a look at the latest and coolest technology products and ... and technology expert, conducted the review and shared with viewers ... to the medical and health fields. , Wearable technology has ... the past couple of years. Well, at CES, NewsWatch TV ...
(Date:3/30/2015)... 2015 Healthy, radiant skin can be ... staff of pharmacists is specially trained and skilled in ... eczema and other conditions. , Most people are unaware ... and/or PCP to tackle most skin conditions and offer ... employed specialty-trained pharmacists who have experience in consulting with ...
Breaking Medicine News(10 mins):Health News:Yonkers Celebrates the Grand Opening of Bella Diosa 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 2Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 3Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 4Health News:World’s First Medical Intelligent Band was Featured on NewsWatch Television on January 30, 2015 2Health News:MedX Pharmacy Offers Skin Care Tips 2
(Date:3/30/2015)... MultiVir Inc. ("MultiVir"), a clinical-stage gene therapy company ... treatment of multiple oncological indications, today announced that it ... with the U.S. Securities and Exchange Commission ("SEC") relating ... its common stock. The number of shares to be ... have not yet been determined. MultiVir has applied to ...
(Date:3/30/2015)... March 30, 2015   GlassesUSA , the online retailer ... $12.5 million in new financing led by Viola Private ... will further GlassesUSA,s aggressive business growth and accelerate their expansion ... online eyewear, both B2C and B2B. GlassesUSA was ... Eldad Rothman , and CTO Roy Yamner . ...
(Date:3/30/2015)... , March 30, 2015 ... Yuval Avni as the company,s new chief executive ... VC, a leading early stage Israeli venture capital firm. ... in general and vascular surgery.        ... today that Sherpa Innoventures is Beta-O2,s newest investor, having ...
Breaking Medicine Technology:MultiVir Files Registration Statement for Proposed Initial Public Offering 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3Beta-O2 Names Dr. Yuval Avni CEO 2Beta-O2 Names Dr. Yuval Avni CEO 3
Cached News: